The Lancet Respiratory Medicine in conversation with
Kokonaiskesto:
7 h 18 min
Eric Lim on treatments for pleural mesothelioma
The Lancet Respiratory Medicine in conversation with
06:17
Anne Chang on the burden of chronic respiratory diseases in Indigenous people
The Lancet Respiratory Medicine in conversation with
09:49
Daniel Steinfort and Shankar Siva on radiotherapy field planning in patients with NSCLC
The Lancet Respiratory Medicine in conversation with
10:23
Daniel Prieto-Alhambra, Annika Jödicke, and Martí Català on vaccination to prevent Long COVID
The Lancet Respiratory Medicine in conversation with
08:16
Sarah Gorst and Tim Nicholson on long COVID outcomes
The Lancet Respiratory Medicine in conversation with
15:32
Betty Raman on multiorgan MRI abnormalities after hospitalisation with COVID-19
The Lancet Respiratory Medicine in conversation with
12:02
Keith Chappell on a bivalent recombinant vaccine for COVID-19
The Lancet Respiratory Medicine in conversation with
08:13
James Chalmers on bronchiectasis across Europe
The Lancet Respiratory Medicine in conversation with
11:57
Richard Costello on management of uncontrolled asthma
The Lancet Respiratory Medicine in conversation with
11:38
Keiju Aokage on segmentectomy for ground-glass-dominant lung cancer
The Lancet Respiratory Medicine in conversation with
05:51
Carol Hodgson on post-discharge outcomes for ECMO patients
The Lancet Respiratory Medicine in conversation with
19:16
Emma Grainger on 10 years of The Lancet Respiratory Medicine
The Lancet Respiratory Medicine in conversation with
13:06
Vivienne Kahlmann and Catharina Moor on the TIRED study
The Lancet Respiratory Medicine in conversation with
09:00
Yves Lacasse on long-term oxygen therapy for COPD
The Lancet Respiratory Medicine in conversation with
17:15
Rachael Evans on living with long COVID
The Lancet Respiratory Medicine in conversation with
13:28
Daniel Munblit and Dale Needham on core outcomes post-COVID-19
The Lancet Respiratory Medicine in conversation with
16:37
Daiana Stolz on antibiotic stewardship in pneumonia
The Lancet Respiratory Medicine in conversation with
10:16
Ablo Wachinou on sleep disordered breathing in Benin
The Lancet Respiratory Medicine in conversation with
10:39
Peter Openshaw and Felicity Liew on corticosteroids in the early in the treatment of COVID
The Lancet Respiratory Medicine in conversation with
14:46
Dinh Bui on preterm birth and lung function deficits
The Lancet Respiratory Medicine in conversation with
05:31
Ruvim Izĭckson on a joint flu and COVID-19 vaccine
The Lancet Respiratory Medicine in conversation with
08:41
Wisia Wedzicha on a vaccine for COPD
The Lancet Respiratory Medicine in conversation with
09:05
Eileen Rubin on patient-centered ARDS
The Lancet Respiratory Medicine in conversation with
17:05
Daniel Altmann on COVID boosters
The Lancet Respiratory Medicine in conversation with
16:11
Michael Kreuter on interstitial lung disease
The Lancet Respiratory Medicine in conversation with
08:28
Bairbre McNicholas and Jie Li on awake prone positioning and COVID-19
The Lancet Respiratory Medicine in conversation with
12:04
Charles Sprung and authors on end-of-life practices in ICUs globally
The Lancet Respiratory Medicine in conversation with
15:41
Christopher Brightling on tezepelumab in patients with moderate-to-severe uncontrolled asthma
The Lancet Respiratory Medicine in conversation with
13:17
Paul Verweij on COVID-19 associated aspergillosis
The Lancet Respiratory Medicine in conversation with
06:36
Ignacio Rubio on COVID-19 pathophysiology and phenotypes
The Lancet Respiratory Medicine in conversation with
09:19
Kiran Shekar on cytokine adsorption and severe COVID-19 pneumonia
The Lancet Respiratory Medicine in conversation with
09:54
Fan Chung on chronic cough and long COVID
The Lancet Respiratory Medicine in conversation with
11:32
Mepolizumab and the treatment of chronic rhinosinusitis
The Lancet Respiratory Medicine in conversation with
07:18
Inhaled budesonide in the treatment of early COVID-19
The Lancet Respiratory Medicine in conversation with
10:24
Tocilizumab and COVID-19
The Lancet Respiratory Medicine in conversation with
05:45
Interferon treatment and COVID-19
The Lancet Respiratory Medicine in conversation with
06:34
Evaluating deterioration in patients with acute COVID-19
The Lancet Respiratory Medicine in conversation with
08:29
Treatment options in patients with systemic sclerosis-associated interstitial lung disease
The Lancet Respiratory Medicine in conversation with
15:45
COVID-19 and severe influenza
The Lancet Respiratory Medicine in conversation with
08:08
The second wave and homeless populations
The Lancet Respiratory Medicine in conversation with
07:57